NFKB1 and myalgic encephalomeyelitis/chronic fatigue syndrome: In the murine model of chronic fatigue syndrome, the combination of AM and AS was found to increase body weight and endurance capacity and to decrease mRNA levels of IL-1β, TNF-α, NF-κB, and p38MAPK [24].